
Csaba Pal Kovesdy MD
Fred Hatch Professor of Medicine/University of Tennessee Health Science Center
Join to view full profile
956 Court AvenueSuite B226Memphis, TN 38163
Phone+1 901-448-2985
Dr. Kovesdy is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Csaba P. Kovesdy, MD, is the Fred Hatch Professor of Medicine in Nephrology and Chief of Nephrology at the University of Tennessee Health Science Center. He serves as the Director of the Clinical Outcomes and Clinical Trials Program in Nephrology and Medical Director of the Clinical Trials Unit at the University of Tennessee Health Science Center in Memphis, Tennessee. Dr. Kovesdy earned his medical degree Summa cum Laude from the University of Pecs Medical School in Pecs, Hungary. He completed his residency in Internal Medicine at the Henry Ford Hospital in Detroit, MI, and a clinical fellowship in Nephrology at the Johns Hopkins Bayview Medical Center in Baltimore, MD.
Dr. Kovesdy’s research interests focus on the clinical investigation of disease mechanisms and outcomes in patients with pre-dialysis chronic kidney disease and ESRD. His research involves clinical trials, observational analyses of large administrative databases and translational research experiments in patients with all stages of kidney disease. He has published his research in over 700 peer-reviewed articles, as well as numerous abstracts and book chapters. He is a Fellow of the American Society of Nephrology, and a member of the European Renal Association, the International Society of Nephrology and the International Society of Renal Nutrition and Metabolism. Dr. Kovesdy is President-Elect of the International Society of Renal Nutrition and Metabolism, and a Co-Director of the Renal Total Nutrition Therapy Course.
Education & Training
Johns Hopkins UniversityFellowship, Nephrology, 1999 - 2001
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1996 - 1999
University of Pécs Medical SchoolClass of 1995, MD, Summa cum laude
Certifications & Licensure
TN State Medical License 2012 - 2028
VA State Medical License 2000 - 2028
MI State Medical License 1996 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Nephrology
Clinical Trials
Publications & Presentations
PubMed
- APOL1 and chronic kidney disease in pediatrics: a study from the Biorepository and Integrative Genomics Initiative.Rima S Zahr, Lokesh Chinthala, Akram Mohammed, Csaba P Kovesdy, Robert L Davis
Pediatric Nephrology. 2026-11-01 - International Society of Nephrology International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic Health.Roberto Pecoits-Filho, Debasish Banerjee, Meg J Jardine, Brendon Neuen, Maria Jose Soler
Kidney International. 2026-10-01 - The Chronic Kidney Disease Care Model: Quantifying Management Strategies for Improving Patient Outcomes in the USA.Andrew H Briggs, Ciaran N Kohli-Lynch, Adrian R Levy, Ziyi Lin, Satabdi Chatterjee
Pharmacoeconomics - Open. 2026-09-01
Journal Articles
- Association Between Malnutrition–Inflammation Score and Risk of Subsequent Self-Reported Bone Fractures in Prevalent Kidney Transplant RecipientsM Z Molnar, C P Kovesdy, Osteoporosis international
- Publisher Correction: Genetic Analysis of over 1 Million People Identifies 535 New Loci Associated with Blood Pressure TraitsCsaba P Kovesdy, Walter Palmas, Nature
- African Americans and Kidney Disease in the 21st Century: Articles from the 2017 Frank M. Norfleet Forum for Advancement of HealthCsaba Kovesdy, MD, American Journal of Kidney Diseases
Other
- Differences in Health Outcomes Associated with Initial Adherence to Oral Antidiabetes Medications Among Veterans with Uncomplicated Type 2 Diabetes: A 5‐Year Survival ...Csaba Kovesdy, MD, Diabetic Medicine
https://www.doximity.com/articles/0924be47-4c6a-47e3-a97b-9235522da733
UpToDate, Wolters Kluwer Health - 2013-04-09 - Differences in Health Outcomes Associated with Initial Adherence to Oral Antidiabetes Medications Among Veterans with Uncomplicated Type 2 Diabetes: A 5‐Year Survival ...Csaba Kovesdy, MD, Diabetic Medicine
https://www.doximity.com/articles/0924be47-4c6a-47e3-a97b-9235522da733
UpToDate, Wolters Kluwer Health - 2012-03-07
Authored Content
- African Americans and Kidney Disease in the 21st Century: Articles from the 2017 Frank M. Norfleet Forum for Advancement of HealthOctober 2018
- US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United StatesFebruary 2018
Press Mentions
Patiromer Use Reduced Potassium in Veterans with HyperkalemiaDecember 5th, 2022
Uric Acid-Lowering Therapy May Increase Risk for CKDJune 17th, 2022
Underuse of Diabetic Kidney Disease Therapies ReportedApril 27th, 2022
Grant Support
- Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets): A Pragmatic, Multi-Center, Randomized Controlled TrialVETERANS HEALTH ADMINISTRATION2022–2027
- Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility TrialUNIVERSITY OF TENNESSEE HEALTH SCI CTR2023–2026
- Therapeutic Interventions to Access Outcomes and Disparities in Chronic Kidney Disease Among VeteransMEMPHIS VA MEDICAL CENTER2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: